It acts on the opioid receptor in the brain to help prevent relapse and reduce alcohol cravings in those who drink. The DuPont Merck Pharmaceutical Co. Now Acamprosate has been granted investigational drug status by the Food and Drug Administration and 21 clinical trials are currently underway to study its effects and side-effects. Cells in the Brain Chemicals in the brain called neurotransmitters become imbalanced after repeated alcohol abuse. When an alcoholic stops drinking, these chemicals become over-excited causing a newly sober person to feel sick and crave a drink. Acamprosate works to calm down those neurotransmitters.
Alcohol works on cells in the brain.
Alcohol alters the function of these cells immediately. This dependency is manifested in a change in chemical signalling between the cells. When a person stops drinking, they re often times left in a hyper-excitable state. Sponsored Links Sober Freelance Writer Available for all your office and on-line needs. Let me help you with your newsletters, articles, and web site content.